MATINAS BIOPHARMA HOLDINGS, INC. Deferred Tax Liabilities, Gross
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) had Deferred Tax Liabilities, Gross of $257.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net
us-gaap:DeferredIncomeTaxLiabilities · last filed 2026-03-31
- 2025-12-31: Deferred Tax Liabilities, Gross $257.00K.
- 2024-12-31: Deferred Tax Liabilities, Gross $257.00K.
- 2023-12-31: Deferred Tax Liabilities, Gross $341.00K.
- 2022-12-31: Deferred Tax Liabilities, Gross $341.00K.
| Period end | Deferred Tax Liabilities, Gross |
|---|---|
| 2025-12-31 | $257.00K 10-K · filed 2026-03-31 |
| 2024-12-31 | $257.00K 10-K · filed 2026-03-31 |
| 2023-12-31 | $341.00K 10-K · filed 2025-04-15 |
| 2022-12-31 | $341.00K 10-K · filed 2024-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |